Potassium%2525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520chloride

# Potassium Chloride ## Overview Potassium chloride (KCL) is an electrolyte supplement used to treat or prevent hypokalemia. It is available in oral and intravenous formulations. ## Primary Indications * Treatment and prevention of hypokalemia. * Potassium repletion in various clinical settings. ## Adult Dosing * **Prevention of Hypokalemia:** Typically 10-20 mEq (0.75-1.5 g) orally once or twice daily. * **Treatment of Hypokalemia:** * **Oral:** 20-60 mEq (1.5-4.5 g) orally per day in 2-4 divided doses. Maximum oral dose is generally 100 mEq (7.5 g) per day, but higher doses may be used cautiously under close monitoring. * **Intravenous (IV):** * **Mild to moderate hypokalemia:** 10-20 mEq (0.75-1.5 g) added to a large volume of IV fluid (e.g., 1 Liter) to infuse over several hours. * **Severe hypokalemia or rapid correction:** Dosing is highly individualized and depends on serum potassium levels, ECG findings, and clinical status. Typically administered at rates not exceeding 20 mEq/hour (for peripheral lines) and 40 mEq/hour (for central lines), but higher rates (up to 100 mEq/hour) may be used in emergencies with continuous ECG monitoring and invasive hemodynamic monitoring. * **Maximum concentration for peripheral IV:** Generally limited to 40 mEq/L (3 g/L) to minimize phlebitis. * **Maximum concentration for central IV:** Can be higher, often up to 100-200 mEq/L (7.5-15 g/L), but requires careful dilution and monitoring. ## Pediatric Dosing * Dosing is based on age, weight, and severity of hypokalemia. Specific recommendations vary. * **General maintenance:** 1-2 mEq/kg/day orally, divided into doses. Maximum daily dose generally 3 mEq/kg/day or 200 mEq/day. * **IV supplementation:** Typically 0.5-1 mEq/kg per dose, infused slowly. Maximum rate of infusion is usually 0.5-1 mEq/kg/hour. * **Exact dosing depends on local protocol and clinical assessment.** ## Dose Adjustments * **Renal Impairment:** Dose must be reduced. Monitor serum potassium closely. In severe renal impairment, potassium supplementation may be contraindicated. * **Adrenal Insufficiency:** Increased susceptibility to hyperkalemia. ## Contraindications * Severe renal impairment. * Conditions associated with hyperkalemia (e.g., Addison's disease, acute dehydration, extensive tissue injury, hyperkalemic periodic paralysis). * Known hypersensitivity to potassium chloride. * Certain gastrointestinal conditions (e.g., untreated Addison's disease, esophageal compression, delayed gastric emptying, intestinal obstruction/atony, peptic ulceration). ## Adverse Effects * **Common:** Nausea, vomiting, diarrhea, abdominal pain, flatulence. * **Serious:** Hyperkalemia (potentially life-threatening), cardiac arrhythmias, cardiac arrest, hypotension, ECG changes (peaked T waves, flattened P waves, prolonged PR interval, QRS widening), muscle weakness, paralysis, gastrointestinal bleeding or perforation (especially with sustained-release oral formulations). ## Key Drug Interactions * **ACE Inhibitors, ARBs, Potassium-Sparing Diuretics (e.g., spironolactone, amiloride, triamterene), NSAIDs, Heparin, Trimethoprim:** Increased risk of hyperkalemia. * **Digitalis Glycosides:** Hypokalemia may increase cardiac glycoside toxicity; hyperkalemia may decrease it. * **Neuromuscular Blocking Agents:** Potassium can affect neuromuscular blockade. ## Monitoring * **Serum Potassium:** Regularly, especially during IV therapy, dose adjustments, and in patients with renal impairment. * **Renal function:** BUN, creatinine. * **ECG:** Especially when administering IV potassium rapidly or in patients with severe hypokalemia or cardiac risk factors. * **Signs and symptoms of hypokalemia and hyperkalemia.** ## Clinical Pearls * Oral potassium chloride formulations can be irritating to the gastrointestinal tract. Taking with food or a large glass of water can help mitigate this. * Sustained-release formulations are often preferred for oral use to reduce GI irritation, but should be used cautiously in patients with GI motility issues. * IV potassium chloride should **always** be diluted in a compatible IV solution. **Never administer as a direct IV push or bolus.** * Rapid IV infusion of potassium chloride can be dangerous and lead to fatal arrhythmias. Strict adherence to infusion rates and concentrations is critical. * The presence of hypomagnesemia can impair the body's ability to correct hypokalemia. Magnesium levels should be assessed and corrected if necessary. *** **Disclaimer:** This information is intended for healthcare professionals and is not a substitute for professional medical advice. Always verify current prescribing information from the manufacturer or other authoritative sources before making clinical decisions. Dosage and recommendations can change.